Skip to Content

Buprenorphine Hydrochloride Injection

Last Updated: May 1, 2020
Status: Current

Products Affected - Description
    • Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 1 count, NDC 12496-0757-01 - discontinued
    • Buprenorphine injection, Pfizer, 0.3 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-2012-32
Reason for the Shortage
    • Pfizer has buprenorphine injection on shortage due to manufacturing delays.
    • Par had buprenorphine injection on shortage due to increased demand.
Available Products
    • Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 5 count, NDC 12496-0757-05
    • Buprenorphine injection, Par Pharmaceuticals, 0.3 mg/mL, 1 mL vial, 5 count, NDC 42023-0179-05

Estimated Resupply Dates

    • Pfizer has buprenorphine 0.3 mg/mL 1 mL Carpuject syringes on back order and the company estimates a release date of May 2020.

Updated

Updated May 1, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide